ATON Group

Executive Summary

ATON Group is a French bioscience company founded in 2008 that aims to transform research into personalized, life-saving medicines. Operating as a synergistic ecosystem of specialized platforms and companies, ATON accelerates and secures the entire drug development process, with the core mission of delivering the right treatment to the right person at the right time. The company is currently in the pre-clinical stage, focusing on building its integrated platform approach to drug development, though specific pipeline details are not publicly disclosed. By leveraging its ecosystem model, ATON seeks to address inefficiencies in traditional drug development and enhance the probability of success for novel therapeutics.

Upcoming Catalysts (preview)

• TBDStrategic Partnership or Collaboration with Major Pharma30% success
• TBDSeries A or B Funding Round50% success
• TBDPreclinical Data Readout from Lead Program40% success